Skip to main content
. 2015 Apr 2;19(1):135. doi: 10.1186/s13054-015-0871-3

Table 3.

Changes of fluid status and cumulative fluid balance over 3 days and outcomes (n = 70)

Fluid status before CRRT Fluid status 3 days later Total death, n (%)
Type 1 Type 2 Type 3 Type 4
Type 1 Cumulative fluid balance, mL 1,664 ± 1,971 3,832 ± 4,291 2,626 ± 3,732 870
Death, n (%) 1/10 (10%) 1/3 (33.3%) 2/3 (66.6%) 0/1 (0%) 4/17 (23.5%)
Type 2 Cumulative fluid balance, mL 1,566 2,365 ± 2,140 3,935 ± 2,130 5,974 ± 3,144
Death, n (%) 0/1 (0%) 1/4 (25%) 0/2 (0%) 2/4 (50%) 3/11 (27.3%)
Type 3 Cumulative fluid balance, mL 571 - 1,601 ± 1,147 3,242 ± 3,296
Death, n (%) 0/1 (0%) 0 1/3 (33.3%) 2/5 (40%) 3/9 (33.3%)
Type 4 Cumulative fluid balance, mL −1,380 ± 3,308 −1,159 ± 3,394 2,461 ± 2,844 2,613 ± 3,962
Death, n (%) 3/4 (75%) 1/5 (20%) 1/4 (25%) 14/20 (70%) 19/33 (57.6%)
Total death, n (%) 4/16 (25%) 3/12 (25%) 4/12 (33.3%) 18/30 (60%) 29/70 (41.4%)

Fluid status: type 1, no overhydration and B-type natriuretic peptide (BNP) normal; type 2, no overhydration but BNP abnormal; type 3, overhydration but BNP normal; type 4, overhydration and BNP abnormal. CRRT, continuous renal replacement therapy.